Daily Study

A broad up session: SPY +2.36%, QQQ +3.42%

Three screens filtered 1,896 US stocks down to 12 names on this page: the top and the bottom of each ordering. 1 of 12 closed lower and 11 higher; small caps (IWM) moved +3.25%.

SPY+2.36%
S&P 500 ETF752.72
QQQ+3.42%
Nasdaq 100 ETF678.63
IWM+3.25%
Russell 2000 ETF282.43
DIA+2.17%
Dow 30 ETF523.30
names screened
1,896
studied in depth
145
on this page
12
screens
3

A record of what moved, not a recommendation.Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRLMethodologyDisclaimer

Each screen starts from a broad filter of US stocks; the candidates are then ordered by a combined fundamentals-and-trend read. The page shows the names at the top and at the bottom of that order, so you see both ends of the same filter, not a pick list. Open any case study for the session, the three-month trend and the latest SEC financials. IEX volume is only the share traded on IEX, so it is compared with its own 20-day average.

Learn more: Top and Bottom of the Screen: An Ordering, Not a Verdict · Where the Numbers Come From: IEX Prices and SEC Filings · Reading the Cash Flow Statement · Return on Equity and Leverage

498matched the screen
60studied in depth
4on this page

Top of the screen

CRCT

Cricut Inc

8.79+0.2%
TechnologyComputer Hardware
3 months+49.4%
52-week range52w low85%high
RSI (14)75
Session
at VWAP 8.741.05× avg vol
Moving averages
above 50dabove 200d
View CRCT chart on TradingView Affiliate
Case study: why CRCT is on this page

Top of this screen: profitable last fiscal year; revenue -0.5% YoY; above its 200-day average; +49.4% over 3 months.

Close 8.79: +0.2% vs previous closeSession (open→close): −0.6%

Session: day range 8.53–8.94, VWAP 8.74 (at VWAP), IEX volume 1.05× its 20-day average. Trend: +49.4% over three months, 85% of the way up its 52-week range, RSI(14) 75, above its 50-day and above its 200-day average.

Intraday chart of CRCT on 2026-11-09
Session (intraday)
Three-month daily chart of CRCT
Three months (daily)
Revenue (latest FY)
$708.8M
Net income (latest FY)
$76.7M
Cash
$174.6M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Cricut Inc filings on SEC EDGAR

HNST

Honest Company Inc

5.17+10.9%
Consumer DefensiveHousehold & Personal Products
3 months+2.2%
52-week range52w low79%high
RSI (14)61
Session
above VWAP 5.030.97× avg vol
Moving averages
above 50dabove 200d
View HNST chart on TradingView Affiliate
Case study: why HNST is on this page

Top of this screen: a net loss last fiscal year; revenue -1.9% YoY; above its 200-day average.

Close 5.17: +10.9% vs previous closeSession (open→close): +12.0%

Session: day range 4.60–5.21, VWAP 5.03 (above VWAP), IEX volume 0.97× its 20-day average. Trend: +2.2% over three months, 79% of the way up its 52-week range, RSI(14) 61, above its 50-day and above its 200-day average.

Intraday chart of HNST on 2026-11-09
Session (intraday)
Three-month daily chart of HNST
Three months (daily)
Revenue (latest FY)
$371.3M
Net income (latest FY)
−$15.7M
Cash
$103.0M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Honest Company Inc filings on SEC EDGAR

Bottom of the screen

ARTV

Artiva Biotherapeutics Inc

4.22+1.8%
HealthcareBiotechnology
3 months−63.4%
52-week range52w low11%high
RSI (14)24
Session
at VWAP 4.211.03× avg vol
Moving averages
below 50dbelow 200d
View ARTV chart on TradingView Affiliate
Case study: why ARTV is on this page

Bottom of this screen: a net loss last fiscal year; revenue -100.0% YoY; below its 200-day average; -63.4% over 3 months.

Close 4.22: +1.8% vs previous closeSession (open→close): +0.5%

Session: day range 4.14–4.25, VWAP 4.21 (at VWAP), IEX volume 1.03× its 20-day average. Trend: −63.4% over three months, 11% of the way up its 52-week range, RSI(14) 24, below its 50-day and below its 200-day average.

Intraday chart of ARTV on 2026-11-09
Session (intraday)
Three-month daily chart of ARTV
Three months (daily)
Revenue (latest FY)
$0
Net income (latest FY)
−$83.9M
Cash
$61.2M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Artiva Biotherapeutics Inc filings on SEC EDGAR

PROK

ProKidney Corp

1.16+0.9%
HealthcareBiotechnology
3 months−21.6%
52-week range52w low14%high
RSI (14)38
Session
below VWAP 1.170.80× avg vol
Moving averages
below 50dbelow 200d
View PROK chart on TradingView Affiliate
Case study: why PROK is on this page

Bottom of this screen: a net loss last fiscal year; revenue +1075.0% YoY; below its 200-day average; -21.6% over 3 months.

Close 1.16: +0.9% vs previous closeSession (open→close): 0.0%

Session: day range 1.11–1.26, VWAP 1.17 (below VWAP), IEX volume 0.80× its 20-day average. Trend: −21.6% over three months, 14% of the way up its 52-week range, RSI(14) 38, below its 50-day and below its 200-day average.

Intraday chart of PROK on 2026-11-09
Session (intraday)
Three-month daily chart of PROK
Three months (daily)
Revenue (latest FY)
$893.0K
Net income (latest FY)
−$69.0M
Cash
$74.9M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: ProKidney Corp filings on SEC EDGAR

1,373matched the screen
60studied in depth
4on this page

Top of the screen

FULT

Fulton Financial Corp

24.14+1.6%
Financial ServicesBanks - Regional
3 months−1.1%
52-week range52w low87%high
RSI (14)60
Session
at VWAP 24.211.01× avg vol
Moving averages
above 50dabove 200d
View FULT chart on TradingView Affiliate
Case study: why FULT is on this page

Top of this screen: profitable last fiscal year; revenue -6.5% YoY; above its 200-day average.

Close 24.14: +1.6% vs previous closeSession (open→close): +0.5%

Session: day range 23.90–24.38, VWAP 24.21 (at VWAP), IEX volume 1.01× its 20-day average. Trend: −1.1% over three months, 87% of the way up its 52-week range, RSI(14) 60, above its 50-day and above its 200-day average.

Intraday chart of FULT on 2026-11-09
Session (intraday)
Three-month daily chart of FULT
Three months (daily)
Revenue (latest FY)
$276.8M
Net income (latest FY)
$391.6M
Cash
$1.11B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Fulton Financial Corp filings on SEC EDGAR

HST

Host Hotels & Resorts Inc

25.29+2.7%
Real EstateREIT - Hotel & Motel
3 months+10.9%
52-week range52w low90%high
RSI (14)59
Session
at VWAP 25.351.24× avg vol
Moving averages
above 50dabove 200d
View HST chart on TradingView Affiliate
Case study: why HST is on this page

Top of this screen: profitable last fiscal year; revenue +7.6% YoY; above its 200-day average; near its 52-week high.

Close 25.29: +2.7% vs previous closeSession (open→close): +1.5%

Session: day range 24.91–25.49, VWAP 25.35 (at VWAP), IEX volume 1.24× its 20-day average. Trend: +10.9% over three months, 90% of the way up its 52-week range, RSI(14) 59, above its 50-day and above its 200-day average.

Intraday chart of HST on 2026-11-09
Session (intraday)
Three-month daily chart of HST
Three months (daily)
Revenue (latest FY)
$6.11B
Net income (latest FY)
$765.0M
Cash
$1.49B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Host Hotels & Resorts Inc filings on SEC EDGAR

Bottom of the screen

SANA

Sana Biotechnology Inc

2.47+5.1%
HealthcareBiotechnology
3 months−34.7%
52-week range52w low7%high
RSI (14)46
Session
above VWAP 2.391.43× avg vol
Moving averages
below 50dbelow 200d
View SANA chart on TradingView Affiliate
Case study: why SANA is on this page

Bottom of this screen: a net loss last fiscal year; below its 200-day average; near its 52-week low; -34.7% over 3 months.

Close 2.47: +5.1% vs previous closeSession (open→close): +4.2%

Session: day range 2.28–2.48, VWAP 2.39 (above VWAP), IEX volume 1.43× its 20-day average. Trend: −34.7% over three months, 7% of the way up its 52-week range, RSI(14) 46, below its 50-day and below its 200-day average.

Intraday chart of SANA on 2026-11-09
Session (intraday)
Three-month daily chart of SANA
Three months (daily)
Revenue (latest FY)
n/a
Net income (latest FY)
−$244.2M
Cash
$41.1M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Sana Biotechnology Inc filings on SEC EDGAR

SMR

NuScale Power Corp

5.43+7.1%
IndustrialsSpecialty Industrial Machinery
3 months−43.3%
52-week range52w low4%high
RSI (14)42
Session
above VWAP 5.391.00× avg vol
Moving averages
below 50dbelow 200d
View SMR chart on TradingView Affiliate
Case study: why SMR is on this page

Bottom of this screen: a net loss last fiscal year; revenue -15.0% YoY; below its 200-day average; near its 52-week low; -43.3% over 3 months.

Close 5.43: +7.1% vs previous closeSession (open→close): +6.2%

Session: day range 4.92–5.59, VWAP 5.39 (above VWAP), IEX volume 1.00× its 20-day average. Trend: −43.3% over three months, 4% of the way up its 52-week range, RSI(14) 42, below its 50-day and below its 200-day average.

Intraday chart of SMR on 2026-11-09
Session (intraday)
Three-month daily chart of SMR
Three months (daily)
Revenue (latest FY)
$31.5M
Net income (latest FY)
−$355.8M
Cash
$513.4M

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: NuScale Power Corp filings on SEC EDGAR

25matched the screen
25studied in depth
4on this page

Top of the screen

AAPL

Apple Inc

350.51+2.4%
TechnologyConsumer Electronics
3 months+16.0%
52-week range52w low96%high
RSI (14)57
Session
at VWAP 350.281.01× avg vol
Moving averages
above 50dabove 200d
View AAPL chart on TradingView Affiliate
Case study: why AAPL is on this page

Top of this screen: profitable last fiscal year; revenue +15.1% YoY; above its 200-day average; near its 52-week high; +16.0% over 3 months.

Close 350.51: +2.4% vs previous closeSession (open→close): +1.6%

Session: day range 344.78–352.28, VWAP 350.28 (at VWAP), IEX volume 1.01× its 20-day average. Trend: +16.0% over three months, 96% of the way up its 52-week range, RSI(14) 57, above its 50-day and above its 200-day average.

Intraday chart of AAPL on 2026-11-09
Session (intraday)
Three-month daily chart of AAPL
Three months (daily)
Revenue (latest FY)
$478.83B
Net income (latest FY)
$132.18B
Cash
$36.30B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Apple Inc filings on SEC EDGAR

MU

Micron Technology Inc

733.34+6.3%
TechnologySemiconductors
3 months−19.5%
52-week range52w low51%high
RSI (14)36
Session
above VWAP 727.401.00× avg vol
Moving averages
below 50dbelow 200d
View MU chart on TradingView Affiliate
Case study: why MU is on this page

Top of this screen: profitable last fiscal year; revenue +256.3% YoY; below its 200-day average; -19.5% over 3 months.

Close 733.34: +6.3% vs previous closeSession (open→close): +4.3%

Session: day range 689.72–744.47, VWAP 727.40 (above VWAP), IEX volume 1.00× its 20-day average. Trend: −19.5% over three months, 51% of the way up its 52-week range, RSI(14) 36, below its 50-day and below its 200-day average.

Intraday chart of MU on 2026-11-09
Session (intraday)
Three-month daily chart of MU
Three months (daily)
Revenue (latest FY)
$133.19B
Net income (latest FY)
$84.97B
Cash
$38.36B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Micron Technology Inc filings on SEC EDGAR

Bottom of the screen

ALNY

Alnylam Pharmaceuticals Inc

156.48+0.3%
HealthcareBiotechnology
3 months−30.0%
52-week range52w low1%high
RSI (14)22
Session
at VWAP 155.941.02× avg vol
Moving averages
below 50dbelow 200d
View ALNY chart on TradingView Affiliate
Case study: why ALNY is on this page

Bottom of this screen: profitable last fiscal year; revenue +65.2% YoY; below its 200-day average; near its 52-week low; -30.0% over 3 months.

Close 156.48: +0.3% vs previous closeSession (open→close): −0.2%

Session: day range 152.35–158.49, VWAP 155.94 (at VWAP), IEX volume 1.02× its 20-day average. Trend: −30.0% over three months, 1% of the way up its 52-week range, RSI(14) 22, below its 50-day and below its 200-day average.

Intraday chart of ALNY on 2026-11-09
Session (intraday)
Three-month daily chart of ALNY
Three months (daily)
Revenue (latest FY)
$3.71B
Net income (latest FY)
$313.7M
Cash
$1.75B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: Alnylam Pharmaceuticals Inc filings on SEC EDGAR

NVDA

NVIDIA Corp

178.64−4.3%
TechnologySemiconductors
3 months−20.3%
52-week range52w low18%high
RSI (14)27
Session
above VWAP 176.725.01× avg vol
Moving averages
below 50dbelow 200d
View NVDA chart on TradingView Affiliate
Case study: why NVDA is on this page

Bottom of this screen: profitable last fiscal year; revenue +65.5% YoY; below its 200-day average; -20.3% over 3 months.

Close 178.64: −4.3% vs previous closeSession (open→close): +3.2%

Session: day range 170.24–179.91, VWAP 176.72 (above VWAP), IEX volume 5.01× its 20-day average. Trend: −20.3% over three months, 18% of the way up its 52-week range, RSI(14) 27, below its 50-day and below its 200-day average.

Intraday chart of NVDA on 2026-11-09
Session (intraday)
Three-month daily chart of NVDA
Three months (daily)
Revenue (latest FY)
$215.94B
Net income (latest FY)
$120.07B
Cash
$22.44B

Prices: Alpaca IEX feed · Financials: SEC EDGAR XBRL · Primary source: NVIDIA Corp filings on SEC EDGAR

The charts use the candlestick, VWAP and moving-average reading taught in our free courses. To pull up any of these tickers yourself, TradingView’s free plan covers it. Affiliate link: we may earn a commission if you subscribe, at no extra cost to you.

Reminder: nothing on this page is investment advice. These names appear because of where they landed in the screen, not because of any view on where the price goes next. Past performance does not indicate future results. See the Disclaimer.